Evotec SE EVO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
7.24quote price arrow up+0.23 (+3.28%)
Volume
55,622
52 week range
6.83 - 13.49
Loading...
  • Open7.09
  • Day High7.24
  • Day Low7.02
  • Prev Close7.01
  • 52 Week High13.49
  • 52 Week High Date07/25/23
  • 52 Week Low6.83
  • 52 Week Low Date03/15/24

Key Stats

  • Market Cap2.571B
  • Shares Out355.08M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-38.28

KEY STATS

  • Open7.09
  • Day High7.24
  • Day Low7.02
  • Prev Close7.01
  • 52 Week High13.49
  • 52 Week High Date07/25/23
  • 52 Week Low6.83
  • 52 Week Low Date03/15/24
  • Market Cap2.571B
  • Shares Out355.08M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change-38.28

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-219.39
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/24/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evotec SE

 

Content From Our Affiliates

Profile

MORE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug...
Craig Johnstone Ph.D.
Chief Operating Officer, Member of the Management Board
Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Address
Essener Bogen 7
Hamburg
22419
Germany